NUMD — Nu-Med Plus Balance Sheet
0.000.00%
- $4.18m
- $4.28m
Annual balance sheet for Nu-Med Plus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.189 | 0.012 | 0.073 | 0.007 | 0.002 |
Prepaid Expenses | |||||
Total Current Assets | 0.538 | 0.012 | 0.08 | 0.013 | 0.009 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.02 | 0.01 | 0 | — | — |
Total Assets | 0.557 | 0.022 | 0.08 | 0.013 | 0.009 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.08 | 0.155 | 0.143 | 0.16 | 0.224 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.089 | 0.155 | 0.143 | 0.16 | 0.224 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.468 | -0.132 | -0.063 | -0.147 | -0.215 |
Total Liabilities & Shareholders' Equity | 0.557 | 0.022 | 0.08 | 0.013 | 0.009 |
Total Common Shares Outstanding |